BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Stanbio Laboratory Release: Improve Your Ketosis Detection


7/12/2012 9:46:33 AM

Cardiff, UK – 17th July 2012 – Stanbio Laboratory, an EKF Diagnostics company, has developed the ß-Hydroxybutyrate LiquiColor® Reagent System to improve the detection of clinically significant ketosis.

Ketosis is elevated levels of ketones in the body that occur when stored fats are broken down in response to a low supply of energy (glucose). Using the reagent system, levels of the ketone ß-Hydroxybutyrate in serum and plasma can be used to clinically diagnose and monitor diabetes mellitus, alcoholism, glycogen storage disease, high fat/low carbohydrate diets, pregnancy, alkalosis, ingestion of isopropyl alcohol, and salicylate poisoning.

As ß-Hydroxybutyrate is the main ketone produced during ketosis (~78%), the blood assay provides a better tool than the nitroprusside test strips commonly used for the detection of ketone bodies in urine, which only detect 22% of ketones present. ß-Hydroxybutyrate also demonstrates excellent stability, making it the most reliable indicator of clinically relevant ketosis and ketoacidosis.

Stanbio Laboratory’s ß-Hydroxybutyrate LiquiColor® Reagent System produces quantitative and objective results and provides an excellent tool for differentiating metabolic acidosis and monitoring therapy. Its precise and sensitive quantitative results enable earlier detection of ketosis and faster patient treatment, thus improving Emergency Room (ER) and Critical Decision Unit (CDU) throughput and efficiency.

To find out more about Stanbio Laboratory’s ß-Hydroxybutyrate LiquiColor® Reagent System please visit http://www.stanbio.com/

About EKF Diagnostics Holdings plc

The EKF Diagnostics Group has expertise across the entire in vitro diagnostics chain, from fermentation and enzyme production, to the manufacture of liquid reagents, the design and building of world-class diagnostic devices and the distribution of rapid test kits for infectious diseases and pregnancy. The EKF range of analysers are a trusted brand in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for the measurement of glucose, lactate, haemoglobin, haematocrit and HbA1c.

To date, the EKF Diagnostics Group has distributors in more than 70 locations around the globe. EKF Diagnostics’ strengths lie in its multi-national research and manufacturing facilities, teams of experienced analysts and engineers in Germany, Ireland, USA and the UK, and a board led by some of world’s foremost authorities in medical diagnostics.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->